APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,872,704 | -75.5% | 75,518 | -41.3% | 0.01% | -73.7% |
| Q2 2023 | $11,720,470 | +35.7% | 128,655 | -1.7% | 0.02% | +35.7% |
| Q1 2023 | $8,634,889 | +31.7% | 130,911 | +3.2% | 0.01% | +27.3% |
| Q4 2022 | $6,556,466 | -23.0% | 126,793 | +1.7% | 0.01% | -26.7% |
| Q3 2022 | $8,515,000 | +3447.9% | 124,671 | +2248.7% | 0.02% | – |
| Q2 2022 | $240,000 | -83.7% | 5,308 | -81.7% | 0.00% | -100.0% |
| Q1 2022 | $1,476,000 | +16.7% | 29,069 | +8.6% | 0.00% | +100.0% |
| Q4 2021 | $1,265,000 | – | 26,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |